Home > Healthcare & Medical Devices > Dialyzers Market
Dialyzers Market size is anticipated to witness appreciable gains from 2023-2032, given the increased burden of hypertension and other chronic diseases. High blood pressure can damage arteries and organs throughout the body including kidneys.
As per a 2019-2020 National Family Health Survey, hypertension impacted 24% and 21% of men and women respectively. This growing disease prevalence will bolster the demand for dialyzer components to remove waste substances from the blood of patients with malfunctioning kidneys. Dialyzers refer to medical devices that use a thin piece of material or artificial membrane to filter impurities from the blood when the kidneys are unable to remove them. This machine provides a means for adding needed components to the blood, controlling its acid-base balance and the content of water and dissolved materials.
The rising prevalence of chronic diseases including diabetes and kidney disorders will be a prominent factor fostering the global dialyzers market trends. Based on statistics from the Australian Institute of Health and Welfare, in 2020, chronic kidney diseases contributed to over 17,700 deaths, representing 11% of all deaths recorded in Australia. Diabetic patients are also at risk of nephropathy disease that affects the kidney. The growing number of elderly people susceptible to diabetes will therefore boost the requirement for dialyzer membranes and other components.
Low flux dialyzers industry share will expand considerably by 2032, on account of the availability of extensive product ranges, allowing clinicians and health professionals to individualize care. This solution is ideal for chronic and acute dialysis where a lower fluid removal rate is desired. Manufacturers have been designing safe, efficient, and biocompatible dialyzers to ensure reduced adverse interactions between material and blood. These attributes have established benchmarks for all membrane developments and improvements, promoting the usage of low flux dialyzers during dialysis treatment.
Dialyzers market share from the hospital end-use segment is predicted to expand considerably over the forecast period, due to the introduction of funding programs to help compensate for financial losses during the COVID-19 pandemic. For example, the U.S. federal government distributed USD 7.5 billion in American Rescue Plan rural funds to hospitals and other healthcare providers to cater to patients in rural areas, with another USD 1 billion to be distributed in early 2022. Moreover, the strong presence of skilled workers and treatment options will encourage patients to conduct dialysis in hospitals and subsequently fuel dialyzer adoption.
Regionally speaking, the Asia Pacific dialyzers market size is likely to observe appreciable growth through 2032, owing to the ever-increasing geriatric population. As per data from the National Health Commission, in 2021, the number of elderly people aged 60 years and above reached 267 million in China. Since older people are prone to chronic ailments including diabetes, the rate of dialysis procedures will rise. Furthermore, the mounting cases of hypertension among adults will be a key contributor to regional industry development over the estimated timeline.
Medica Group, Toray Medical, Jihua Medical Apparatus and Instruments, Kawasumi Laboratories (Sumitomo Bakelite Company Limited), Fresenius Medical Care, Browndove Healthcare, Nikkiso, Baxter International, and B. Braun are some of the key players in the dialyzers market. These companies are focusing on mergers and acquisitions and other strategies to reinforce their presence in the global market. For instance, in March 2022, B. Braun acquired a specialist in dialysis concentrate preparation, Intermedt Medizin & Technik GmbH, to integrate their comprehensive range of services and products for dialysis therapy into its B. Braun Avitum division.
Chronic kidney diseases degrade the podocyte cells that maintain the blood filtration system, leading to an increased reliance on dialysis treatment. These factors have highlighted the potential to discover effective treatments for CKDs.